Reversing diabetic retinopathy! Besides lowering intraocular pressure, risudil has yielded these new discoveries.

If you or a family member is battling diabetic retinopathy, this latest medical discovery could be a game-changer. Scientists have found that risudil, a commonly used intraocular pressure-lowering drug, has shown surprising potential in treating diabetic retinopathy!

Diabetic retinopathy: The silent killer of vision

Diabetic retinopathy is the leading cause of blindness among working-age people . In China , over one-third of the approximately 110 million diabetic patients will develop this condition. Traditional treatments mainly rely on laser therapy, intraocular injections, and surgery, all of which have limited effectiveness and are somewhat invasive.

Risudil: More Than Just Lowering Intraocular Pressure

Risudil is a common medication for treating glaucoma, primarily working by lowering intraocular pressure to protect the optic nerve. However, recent research has found that its effectiveness in treating diabetic retinopathy may be far greater than previously thought!

Breakthrough in scientific research

A groundbreaking study published in the journal *Ophthalmology Research* in 2022 showed that risudil can:

1. Significantly reduces retinal inflammation. The core mechanism of diabetic retinopathy is chronic inflammation, and risudil can inhibit the expression of various inflammatory factors.

2. Protects the blood-retinal barrier - Strengthen vascular structure, reduce leakage, and prevent disease progression.

3. Inhibits pathological angiogenesis - Prevent the formation of new blood vessels that lead to blindness at the source

4. Directly protects retinal nerve cells - Reduce cell apoptosis and preserve existing visual function

Why this is a major discovery

Compared to traditional treatments, risudil offers multiple protective mechanisms :

Dual function of prevention and treatment : It can be used for both early prevention and mid-term treatment.

Non-invasive drug delivery : Simply drop the drops into the eye, avoiding the pain and risks of intraocular injection.

Multi-target action : Simultaneously targets multiple aspects of inflammation, vascular leakage, and angiogenesis.

High safety profile : As a long-term glaucoma medication, its safety profile has been verified.

How to use risudil to treat diabetic retinopathy

Based on clinical research, the recommended treatment plan is as follows:

Early lesions: 1 drop once or twice daily.

Mid-stage lesions: 2-3 times daily, 1 drop each time.

Combination therapy: In conjunction with existing treatment regimens

Important Note : The specific usage plan must be formulated by a professional ophthalmologist based on the patient's condition!

Action recommendations for people with diabetes

1. Regular check-ups : Diabetic patients should have a fundus examination at least once a year.

2. Strictly control blood sugar : keep glycated hemoglobin below 7%.

3. Comprehensive management : Simultaneously controlling multiple indicators such as blood pressure and blood lipids.

4. Timely intervention : Treatment should begin immediately upon detection of early-stage lesions.

🏆 Asakusa Cosmetics provides you with

✔️ Genuine Lisudil Hydrochloride

✔️ Hospital prescription

✔️ Online doctor consultation

✔️ Pharmacist's Medication Instructions

✔️ Comprehensive after-sales tracking service

The new discovery of risudil in the treatment of diabetic retinopathy has brought new hope to millions of patients. This repurposing of an old drug may be the solution you've been looking for. Don't wait until your vision deteriorates significantly before taking action; early intervention is key to preserving your eyesight!

⚠️ Friendly reminder: This article is for reference only. Please consult your doctor for specific medication advice.

----------------------------------------------------------------------------------------------

📞Welcome to scroll down to contact customer service, purchase online, and have it shipped directly to your door.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.